Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Analysis of saliva samples from oncological patients treated with 5-fluorouracil and leucovorin calcium by scanning electron microscopy with energy dispersive system.

Mazzeo MA, Linares JA, López MM, Bachmeier E, Wietz FM, Galván V, Valentinuzzi MC, Riveros JA, Finkelberg A.

J Oral Pathol Med. 2013 Nov;42(10):788-92. doi: 10.1111/jop.12078. Epub 2013 May 6.

PMID:
23647127
2.

Oral signs of intravenous chemotherapy with 5-Fluorouracil and Leucovorin calcium in colon cancer treatment.

Mazzeo MA, Linares JA, Campos ML, Busamia BE, Dubersarsky C, Lavarda M, Jarchum G, Finkelberg AB.

Med Oral Patol Oral Cir Bucal. 2009 Mar 1;14(3):E108-13.

5.

Comparison of the levogyre and dextro-levogyre forms of leucovorin in a phase III trial of bimonthly LV5FU2 versus monthly 5-fluorouracil and high-dose leucovorin for patients with stage II and III colon cancer (GERCOR C96.1).

Baumgaertner I, Quinaux E, Khalil A, Louvet C, Buyse M, de Gramont A, André T; GERCOR Group..

Clin Colorectal Cancer. 2010 Apr;9(2):E5-10. doi: 10.3816/CCC.2010.n.027.

PMID:
20378497
6.

Adjuvant systemic chemotherapy with 5-fluorouracil and leucovorin in colon cancer: a monoinstitutional institutional experience.

Jirillo A, Stefani M, Vascon F, Lonardi S.

Immunopharmacol Immunotoxicol. 2008;30(2):235-42. doi: 10.1080/08923970801949083 .

PMID:
18569081
7.

Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: study design and preliminary safety results. Groupe d'Etude et de Recherche Clinique en Oncologie Radiotherapies.

André T, Colin P, Louvet C, Gamelin E, Bouche O, Achille E, Colbert N, Boaziz C, Piedbois P, Tubiana-Mathieu N, Boutan-Laroze A, Flesch M, Billiau V, Buyse M, Gramont A; Groupe d'Etude et de Recherche Clinique en Oncologie Radiotherapies..

Semin Oncol. 2001 Feb;28(1 Suppl 1):35-40.

PMID:
11273588
8.

Resection of hepatic metastasis after 5-fluorouracil and cofactor for colon cancer.

Costantini CL, Reid TR, Bouvet M.

Hepatogastroenterology. 2009 May-Jun;56(91-92):645-9.

PMID:
19621672
9.

[Treatment of rectal cancer and follow up].

Charúa-Guindic L.

Rev Gastroenterol Mex. 2007 Nov;72 Suppl 2:126-31. Spanish. No abstract available.

PMID:
18277500
10.

UFT/leucovorin vs 5-FU/leucovorin in colon cancer.

Smith RE, Lembersky BC, Wieand HS, Colangelo L, Mamounas EP.

Oncology (Williston Park). 2000 Oct;14(10 Suppl 9):24-7.

12.

Efficacy of adjuvant 5-flurouracil and leucovorin in metastatic gall bladder carcinoma.

Aich RK, Deb AR, Pal S, Biswas LN, Das D, Roy A.

Indian J Gastroenterol. 2006 Sep-Oct;25(5):267-8. No abstract available.

PMID:
17090856
13.

Cost-effectiveness analysis of capecitabine compared with bolus 5-fluorouracil/l-leucovorin for the adjuvant treatment of colon cancer in Japan.

Shiroiwa T, Fukuda T, Shimozuma K, Ohashi Y, Tsutani K.

Pharmacoeconomics. 2009;27(7):597-608. doi: 10.2165/11310110-000000000-00000.

PMID:
19663530
14.

Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer.

Scheithauer W, Depisch D, Kornek G, Pidlich J, Rosen H, Karall M, Prochaska M, Ernst A, Sebesta C, Eckhardt S.

Cancer. 1994 Mar 15;73(6):1562-8.

15.

Bolus/infusional 5-fluorouracil and folinic acid. A report on two prospective, consecutive phase II studies with 5-fluorouracil dose escalation.

Mackean MJ, Cassidy J, Jodrell DI, Paul J, Reed NS, Canney PA, Yosef H, Habeshaw T, Robertson AG, McInnes A, Twelves CJ.

Br J Cancer. 1998 May;77(9):1480-6.

16.
17.

Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.

Focan C, Bury J, Beauduin M, Herman ML, Vindevoghel A, Lecomte M, Brohée D, Canon JL, Focan-Henrard D; GRECCR Belgium..

Anticancer Res. 2000 Nov-Dec;20(6C):4665-72.

PMID:
11205198
18.

A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.

Yeh KH, Cheng AL, Lin MT, Hong RL, Hsu CH, Lin JF, Chang KJ, Lee PH, Chen YC.

Anticancer Res. 1997 Sep-Oct;17(5B):3867-71.

PMID:
9427794
19.

A phase I study of 5-fluorouracil, leucovorin and levamisole.

Cleary JF, Arzoomanian R, Alberti D, Feierabend C, Storer B, Witt P, Carbone P, Wilding G.

Cancer Chemother Pharmacol. 1997;39(4):300-6.

PMID:
9025770
20.

The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test.

Choi K, Lee SS, Oh SJ, Lim SY, Lim SY, Jeon WK, Oh TY, Kim JW.

Clin Nutr. 2007 Feb;26(1):57-62. Epub 2006 Sep 1.

PMID:
16949180

Supplemental Content

Support Center